301 related items for PubMed ID: 23539930
1. Diagnosis and management of congenital adrenal hyperplasia: 20-year experience in Songklanagarind Hospital.
Jaruratanasirikul S, Thongseiratch T.
J Med Assoc Thai; 2013 Mar; 96(3):288-93. PubMed ID: 23539930
[Abstract] [Full Text] [Related]
2. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
3. [Congenital adrenal hyperplasia].
Stanić M, Nesović M.
Med Pregl; 1999 Jan; 52(11-12):447-54. PubMed ID: 10748766
[Abstract] [Full Text] [Related]
4. [Screening for congenital adrenal hyperplasia in Hungary].
Sólyom J.
Orv Hetil; 1989 Sep 10; 130(37):1979-82, 1985-6. PubMed ID: 2780047
[Abstract] [Full Text] [Related]
5. Assessment of the 21-hydroxylase deficiency and the adrenal functions in young females with Turner syndrome.
Onder A, Aycan Z, Cetinkaya S, Kendirci HN, Bas VN, Agladioglu SY.
J Pediatr Endocrinol Metab; 2012 Sep 10; 25(7-8):681-5. PubMed ID: 23155693
[Abstract] [Full Text] [Related]
6. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency.
Lutfallah C, Wang W, Mason JI, Chang YT, Haider A, Rich B, Castro-Magana M, Copeland KC, David R, Pang S.
J Clin Endocrinol Metab; 2002 Jun 10; 87(6):2611-22. PubMed ID: 12050224
[Abstract] [Full Text] [Related]
7. Androgens concentrations and second-to fourth-digit ratio (2D:4D) in girls with congenital adrenal hyperplasia (21-hydroxylase deficiency).
Oswiecimska JM, Ksiazek A, Sygulla K, Pys-Spychala M, Roczniak GR, Roczniak W, Stojewska M, Ziora K.
Neuro Endocrinol Lett; 2012 Jun 10; 33(8):787-91. PubMed ID: 23391972
[Abstract] [Full Text] [Related]
8. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
Xiao HW, Ma HM, Su Z, Du ML, Li YH, Chen HS, Chen QL.
Zhonghua Er Ke Za Zhi; 2012 Apr 10; 50(4):301-7. PubMed ID: 22801236
[Abstract] [Full Text] [Related]
9. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza D, Pirazzoli P, Zappulla F.
Pediatrics; 1996 Sep 10; 98(3 Pt 1):362-7. PubMed ID: 8784357
[Abstract] [Full Text] [Related]
10. Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization.
Sólyom J, Gács G, Keszei K, Láng K, Orley J, Petheö I, Ságodi L.
Acta Endocrinol (Copenh); 1987 Jul 10; 115(3):413-8. PubMed ID: 3039770
[Abstract] [Full Text] [Related]
11. Adrenocorticotropin stimulation test in congenital adrenal hyperplasia: comparison between standard and low dose test.
Panamonta O, Thinkhamrop B, Kirdpon W, Pudtawaro LO, Sungsahachart D.
J Med Assoc Thai; 2003 Jul 10; 86(7):634-40. PubMed ID: 12948258
[Abstract] [Full Text] [Related]
12. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
Cavarzere P, Samara-Boustani D, Flechtner I, Dechaux M, Elie C, Tardy V, Morel Y, Polak M.
Eur J Endocrinol; 2009 Aug 10; 161(2):285-92. PubMed ID: 19451212
[Abstract] [Full Text] [Related]
13. [Contemporary diagnosis and therapy in women with congenital adrenal hyperplasia].
Maciejewska-Jeske M, Meczekalski B.
Pol Merkur Lekarski; 2013 Nov 10; 35(209):297-9. PubMed ID: 24575652
[Abstract] [Full Text] [Related]
14. Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3beta-hydroxysteroid dehydrogenase deficiency.
Johannsen TH, Mallet D, Dige-Petersen H, Müller J, Main KM, Morel Y, Forest MG.
J Clin Endocrinol Metab; 2005 Apr 10; 90(4):2076-80. PubMed ID: 15671104
[Abstract] [Full Text] [Related]
15. Persistent testicular delta5-isomerase-3beta-hydroxysteroid dehydrogenase (delta5-3beta-HSD) deficiency in the delta5-3beta-HSD form of congenital adrenal hyperplasia.
Schneider G, Genel M, Bongiovanni AM, Goldman AS, Rosenfield RL.
J Clin Invest; 1975 Apr 10; 55(4):681-90. PubMed ID: 164481
[Abstract] [Full Text] [Related]
16. Diagnosis of adrenal cortical dysfunction by liquid chromatography-tandem mass spectrometry.
Kao PC, Machacek DA, Magera MJ, Lacey JM, Rinaldo P.
Ann Clin Lab Sci; 2001 Apr 10; 31(2):199-204. PubMed ID: 11337910
[Abstract] [Full Text] [Related]
17. Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Körner A, Kiess W, Kratzsch J, Dörr HG.
Acta Paediatr; 2009 May 10; 98(5):885-91. PubMed ID: 19236311
[Abstract] [Full Text] [Related]
18. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
Santos CM, Abad LR, Cua SC, Domingo CF.
Southeast Asian J Trop Med Public Health; 2003 May 10; 34 Suppl 3():174-8. PubMed ID: 15906729
[Abstract] [Full Text] [Related]
19. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era.
Lee CT, Tung YC, Hsiao PH, Lee JS, Tsai WY.
J Formos Med Assoc; 2010 Feb 10; 109(2):148-55. PubMed ID: 20206839
[Abstract] [Full Text] [Related]
20. Raised 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
Iqbal S, Khan AH.
J Coll Physicians Surg Pak; 2013 May 10; 23(5):373-4. PubMed ID: 23673184
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]